| The application of ferroptosis in diseases Y Qiu, Y Cao, W Cao, Y Jia, N Lu Pharmacological Research 159, 104919, 2020 | 336 | 2020 |
| ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation D Bai, J Du, X Bu, W Cao, T Sun, J Zhao, Y Zhao, N Lu Autophagy 18 (7), 1673-1693, 2022 | 44 | 2022 |
| Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis Y Cao, W Cao, Y Qiu, Y Zhou, Q Guo, Y Gao, N Lu Pharmacological Research 159, 104981, 2020 | 37 | 2020 |
| Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota D Bai, T Sun, J Zhao, J Du, X Bu, W Cao, Y Zhao, N Lu Cancer letters 515, 73-85, 2021 | 33 | 2021 |
| Hypoplastic left heart syndrome: signaling & molecular perspectives, and the road ahead S Datta, W Cao, M Skillman, M Wu International Journal of Molecular Sciences 24 (20), 15249, 2023 | 7 | 2023 |
| The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells J Zhao, D Bai, L Qi, W Cao, J Du, C Gu, C Zhou, Y Gao, L Zhang, Y Zhao, ... British Journal of Pharmacology 180 (8), 1072-1089, 2023 | 7 | 2023 |